Viewing Study NCT02482532


Ignite Creation Date: 2025-12-24 @ 9:38 PM
Ignite Modification Date: 2026-01-04 @ 3:42 AM
Study NCT ID: NCT02482532
Status: COMPLETED
Last Update Posted: 2022-02-04
First Post: 2015-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory Melanoma
Sponsor: Gary Doolittle
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module